POSTER SESSION III Tuesday, March 25, 2003   —  9:30 AM - 12:00 Noon Exhibit Hall A - C PATHOBIOLOGY 174 A Study of Three Novel Tumor Suppressor Genes in the Progression of Ductal Carcinoma of the Breast (1350) TJ Fuja, F Lin, PJ Bryant University of California, Irvine, Irvine, CA 175 Expression of the ETV6-NTRK3 Gene Fusion in Human Secretory Breast Carcinoma (1357) N Makretsov, D Huntsman, C Tognon, N Melnik, PHB Sorensen Academic Pathology Department of University of British Columbia and Vancouver General Hospital; Children's and Women's Health Center of British Columbia, Vancouver, BC, Canada 176 Expression of Estrogen Receptor and Progesterone Receptor in Paired Cancerous and Normal Endometrial Tissues from the Same Patients (1356) P Liu, P Chen, C Aoyama, Q Ji Olive View-UCLA Medical Center, Sylmar, CA 177 The Protein C System in Placental Massive Perivillous Fibrin Deposition (1368) AM Svensson, BL Waters, AJ Goodwin, L Simmons-Arnold, EG Bovill University of Vermont College of Medicine, Burlington, VT 178 Thy-1 Protein, a Potential Tumor Marker, Identified in Various Tumor Cells with Nuclear Localization (1355) R Li, P Bourne, Z-W Ma University of Rochester Medical Center, Rochester, NY 179 Versican Expression in Adult Human Tumors - A Tissue Microarray Based Study (1349) WL Frankel, P Wen, NS Pellegata, ML Prasad Ohio State University Medical Center, Columbus, OH 180 Localization of the ABCG2 Mitoxantrone Resistance-Associated Protein in Normal Tissues (1348) PA Fetsch, A Abati, K Morisaki, Y Honjo, K Mittal, S Hewitt, SE Bates National Institutes of Health/National Cancer Institute, Bethesda, MD; New York University School of Medicine, New York, NY 181 MSG1/CITED1 Protein Expression Profiling of Routinely Fixed Human Normal Tissues and Malignant Tumors Using High Throughput Tissue Microarray Technique (1364) NS Pellegata, Y Huang, S Jones, A de la Chapelle, ML Prasad Ohio State University; James Cancer Center, Columbus, OH 182 Suppression of Cutaneous Fatty Acid Binding Protein Inhibits Tumorigenicity through down Regulation of Vascular Endothelial Growth Factor Expression in Prostate Cancer Cells (1361) EA Morgan, J Adamson, C Beesley, Y Mei, CS Foster, P Smith, YQ Ke Liverpool University, Liverpool, United Kingdom 183 Reverse Polarization of Cells with Expression of MUC1 in the Stroma-Facing Surfaces May Be a Key Factor in the Pathogenesis and Morphogenesis of Invasive Micropapillary Carcinoma (1362) H Nassar, V Pansare, H Zhang, G Kotcher, M Che, W Sakr, R Ali-Fehmi, D Grignon, F Sarkar, J Cheng, NV Adsay Harper University Hospital; The Karmanos Cancer Institute; Wayne State University School of Medicine, Detroit, MI 184 Distinctive Apoptosis Pattern "Switch" during Colonic Tumorigenesis (1345) CM Brodie, PL Crotty, EF Gaffney St. James's Hospital; Adelaide and Meath, Inc., The National Children's Hospital; Trinity College, Dublin, Ireland 185 Centrosome Abnormalities and Chromosome Instability Occur Together in Carcinoma In-Situ (1365) G Pihan, Y Zhou, S Doxsey, J Wallace University of Massachusetts Medical School, Worcester, MA 186 Sp1 Mediated Transcriptional Control of Fibroblast Growth Factor Receptor 4 in Human Rhadomyosarcomas (1343) SL Asa, S Yu, L Zheng, M Ladanyi, S Ezzat University Health Network, and Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada; Memorial Sloan-Kettering Cancer Center, New York, NY 187 Aberrant Expression of Tight Junction Proteins ZO-1, Claudin-1 and Occludin in Synovial Sarcoma: An Immunohistochemical Study with Ultrastructural Correlation (1344) SD Billings, SV Walsh, A Nusrat, C Fisher, SW Weiss, AL Folpe Indiana University, Indianapolis, IA; Ninewells Hospital, Dundee, United Kingdom; Emory University, Atlanta, GA; Royal Marsden Hospital, London, United Kingdom 188 Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism in Sarcoidosis (1354) TS Kim, HY Hong, CJ Kim, I Lee Inha University College of Medicine, Incheon, Korea; Seoul National University College of Medicine, Seoul, Korea; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 189 Microarray Study of Apoptotic Pathway in Keloid vs Normal Skin (1363) M Nassiri, H Wollery-Lloyd, V Vincek, B Berman University of Miami School of Medicine, Miami, FL 190 p53 Overexpression in Transplant Patients with Skin Squamous Cell Carcinoma (1369) A Vijayvargiya, N Laver, A Perepletchikov, X Pang, A Mithoefer, R Freeman New England Medical Center, Boston, MA 191 Adenovirus and Polyomavirus in Human Lymphomas: An Inconclusive Association (1347) V Fernandez Soria, G Fedele, J Hernandez-Losa, A Tenorio, C Parada Cobo, R Sanchez-Prieto, S Ramon y Cajal Clinica Puerta de Hierro, Madrid, Madrid, Spain; Instituto Carlos III, Majadahonda, Madrid, Spain 192 Histology of Splenic Allograft Rejection in MHC-Matched and MHC-Disparate Miniature Swine (1351) SL Houser, FJ Dor, B Gollackner, DK Cooper Massachusetts General Hospital, Boston, MA 193 A Human Pituitary Cell Line HP75: A Model for Pathological Hormone Production with Abberant Expression of Transcription Factors (1360) S Miyai, RY Osamura, RV Lloyd Tokai University School of Medicine, Isehara, Kanagawa, Japan; Mayo Clinic Medical School, Rochester, MN 194 Unusual Morphological Patterns of Acute Thymic Involution in a Case with Congenital Hypercorticism (1367) DI Staribratova, DI Dikov Medical University, Plovdiv, Bulgaria 195 HSP 70 Is Cytoprotective Against the Pathologic Changes Induced by Nicotine in Vascular Smooth Muscle Cells In Vitro (273) M DeSouza, C Williams, G Albaugh, R Armour, L Reid, L Strande, C Hewitt, J Alexander UMDNJ/Cooper Health System, Camden, NJ